The head of the Food and Drug Administration’s Center for Biologics Evaluation and Research is stepping down next month after a series of controversial decisions involving vaccines and gene therapies. Vinay Prasad was previously ousted from his position at the FDA last summer before returning.
Matthew Herper, senior writer at STAT, joins us to discuss.
This article was originally published on WBUR.org.
Copyright 2026 WBUR
